Clinical Trials in Chicago

Showing 6081-6100 of 15,574 trials

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

NCT03912831

This study has 2 parts: Phase 1A and Phase 1B. The primary objectives of Phase 1A are to evaluate the safety of KITE-439 and to determine a recommended Phase 1B dose. The primary objective of Phase 1B is to estimate the efficacy of KITE-439 in adults who are human leukocyte antigen (HLA)-A\*02:01+ and have relapsed/refractory human papillomavirus (HPV)16+ cancers.

Human Papillomavirus (HPV) 16+ Relapsed/Refractory Cancer

Gilead Sciences8 participantsStarted Apr 2019

Gilbert, Arizona, United States • Duarte, California, United States • Los Angeles, California, United States +6 more locations

COMPLETEDPhase 22.2 miles

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

NCT03737851

The purpose of this study is to evaluate the safety and efficacy of elezanumab in participants with relapsing Multiple Sclerosis (RMS).

Multiple Sclerosis (MS)

AbbVie208 participantsStarted Dec 2018

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Berkeley, California, United States +46 more locations

Study to Evaluate the Safety and Efficacy of KITE-439 in HLA-A*02:01+ Adults With Relapsed/Refractory HPV16+ Cancers

A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

Find Trials by Condition in Chicago

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19

Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer

Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma

Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer

Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)

Real-World Use of Novel Treatments in Patients With Spinal Muscular Atrophy (SMA): A Multi-Site Retrospective Chart Review of Pediatric SMA Patients Outside of the United States

Trial to Evaluate the Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis

A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult and Adolescent Patients With Moderate-to-Severe Atopic Hand and Foot Dermatitis (Liberty-AD-HAFT)

A Study of LY3410738 in Healthy Adult Participants

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

A Study of TAK-994 in Adults With Narcolepsy

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Verily Watch Cardio (AF and ECG) Study

Medibio DDA Confirmatory Performance Study

The Effects of ADHD Medication (TEAM) Study

Study of the CD40 Agonistic Monoclonal Antibody APX005M

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function